Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Non-Current Deffered Revenue (2017 - 2018)

Iovance Biotherapeutics (IOVA) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $230000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $230000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $230000.0, a N/A change, with the full-year FY2018 number at $230000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $230000.0 for Q4 2018 at Iovance Biotherapeutics.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $230000.0 in Q4 2018 to a low of $230000.0 in Q4 2018.